These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 8869642

  • 1. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH, Nieuwenbroek NM, Verheijen JH.
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [Abstract] [Full Text] [Related]

  • 2. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
    Bakker AH, Rehberg EF, Marotti KR, Verheijen JH.
    Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
    [Abstract] [Full Text] [Related]

  • 3. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG, Kalyan N, Wilhelm J, Hum WT, Rappaport R, Cheng SM, Dheer S, Urbano C, Hartzell RW, Ronchetti-Blume M.
    J Biol Chem; 1988 Feb 25; 263(6):2917-24. PubMed ID: 3125172
    [Abstract] [Full Text] [Related]

  • 4. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ, Veerman H, Pannekoek H.
    J Biol Chem; 1986 Oct 25; 261(30):14214-8. PubMed ID: 3021732
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 6. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins.
    de Vries C, Veerman H, Blasi F, Pannekoek H.
    Biochemistry; 1988 Apr 05; 27(7):2565-72. PubMed ID: 3132969
    [Abstract] [Full Text] [Related]

  • 7. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG, Jaskunas SR, Vlahos CJ, Bang NU.
    J Biol Chem; 1990 Aug 25; 265(24):14606-11. PubMed ID: 2117612
    [Abstract] [Full Text] [Related]

  • 8. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA, Caspers MP, Chang GT, Pouwels PH, Enger-Valk BE, Verheijen JH.
    Biochemistry; 1989 Sep 05; 28(18):7318-25. PubMed ID: 2510823
    [Abstract] [Full Text] [Related]

  • 9. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V, Medved L, Lijnen HR, Ingham K.
    J Biol Chem; 1995 Apr 14; 270(15):8680-5. PubMed ID: 7721771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D, Lijnen HR, Piérard L, de Foresta F, Demarsin E, Jacobs P, De Wilde M, Bollen A, Collen D.
    J Biol Chem; 1987 Aug 25; 262(24):11779-84. PubMed ID: 3114253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS, Marshall JM, Dawson KM, Cederholm-Williams SA, Ponting CP.
    Biochem J; 1998 Jul 01; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.
    Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L.
    J Biol Chem; 1990 Jul 25; 265(21):12184-91. PubMed ID: 2115513
    [Abstract] [Full Text] [Related]

  • 18. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
    Langer-Safer PR, Ahern TJ, Angus LB, Barone KM, Brenner MJ, Horgan PG, Morris GE, Stoudemire JB, Timony GA, Larsen GR.
    J Biol Chem; 1991 Feb 25; 266(6):3715-23. PubMed ID: 1847387
    [Abstract] [Full Text] [Related]

  • 19. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L, Lijnen HR, Van Nuffelen A, Demarsin E, Collen D.
    Thromb Haemost; 1990 Aug 13; 64(1):53-60. PubMed ID: 2148847
    [Abstract] [Full Text] [Related]

  • 20. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jun 13; 303(2):222-30. PubMed ID: 8512311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.